Point mutations in vascular smooth muscle α-actin (SM α-actin), encoded by the gene ACTA2, are the most prevalent cause of familial thoracic aortic aneurysms and dissections (TAAD). Here, we provide the first molecular characterization, to our knowledge, of the effect of the R258C mutation in SM α-actin, expressed with the baculovirus system. Smooth muscles are unique in that force generation requires both interaction of stable actin filaments with myosin and polymerization of actin in the subcortical region. Both aspects of R258C function therefore need investigation. Total internal reflection fluorescence (TIRF) microscopy was used to quantify the growth of single actin filaments as a function of time. R258C filaments are less stable than WT and more susceptible to severing by cofilin. Smooth muscle tropomyosin offers little protection from cofilin cleavage, unlike its effect on WT actin. Unexpectedly, profilin binds tighter to the R258C monomer, which will increase the pool of globular actin (G-actin). In an in vitro motility assay, smooth muscle myosin moves R258C filaments more slowly than WT, and the slowing is exacerbated by smooth muscle tropomyosin. Under loaded conditions, small ensembles of myosin are unable to produce force on R258C actin-tropomyosin filaments, suggesting that tropomyosin occupies an inhibitory position on actin. Many of the observed defects cannot be explained by a direct interaction with the mutated residue, and thus the mutation allosterically affects multiple regions of the monomer. Our results align with the hypothesis that defective contractile function contributes to the pathogenesis of TAAD.
Point mutations in vascular smooth muscle α-actin (SM α-actin), encoded by the gene ACTA2, are the most prevalent cause of familial thoracic aortic aneurysms and dissections (TAAD). Here, we provide the first molecular characterization, to our knowledge, of the effect of the R258C mutation in SM α-actin, expressed with the baculovirus system. Smooth muscles are unique in that force generation requires both interaction of stable actin filaments with myosin and polymerization of actin in the subcortical region. Both aspects of R258C function therefore need investigation. Total internal reflection fluorescence (TIRF) microscopy was used to quantify the growth of single actin filaments as a function of time. R258C filaments are less stable than WT and more susceptible to severing by cofilin. Smooth muscle tropomyosin offers little protection from cofilin cleavage, unlike its effect on WT actin. Unexpectedly, profilin binds tighter to the R258C monomer, which will increase the pool of globular actin (G-actin). In an in vitro motility assay, smooth muscle myosin moves R258C filaments more slowly than WT, and the slowing is exacerbated by smooth muscle tropomyosin. Under loaded conditions, small ensembles of myosin are unable to produce force on R258C actin-tropomyosin filaments, suggesting that tropomyosin occupies an inhibitory position on actin. Many of the observed defects cannot be explained by a direct interaction with the mutated residue, and thus the mutation allosterically affects multiple regions of the monomer. Our results align with the hypothesis that defective contractile function contributes to the pathogenesis of TAAD.
actin | myosin II | smooth muscle | thoracic aortic aneurysms | vascular disease T horacic aortic aneurysms and dissections (TAAD) are the 18th most common cause of death in individuals in the United States (1) . The high degree of mortality is partly due to the fact that aneurysms tend to be asymptomatic until a lifethreatening acute aortic dissection occurs. Familial TAAD is an autosomal dominant disorder with variable penetrance, which is characterized by enlargement or dissection of the thoracic aorta (reviewed in 2). The most prevalent genetic cause of familial TAAD, responsible for ∼15% of all cases, are mutations in vascular smooth muscle α-actin (SM α-actin), encoded by the gene ACTA2. More than 40 mutations in ACTA2 have been identified to date (3) (4) (5) . Intriguingly, ACTA2 mutations also differentially predispose individuals to occlusive vascular diseases, such as premature coronary artery disease and strokes (6) . ACTA2 mutations thus can lead to either dilation of large elastic arteries like the aorta or occlusion of smaller muscular arteries.
SM α-actin is the most abundant protein in vascular smooth muscle cells, constituting ∼40% of the total protein and ∼70% of the total actin, with the rest composed of β-and γ-cytoplasmic actin. Actin is critical for contraction and force production by smooth muscle cells, as well as for their proliferation and migration. Dissected aortas show several characteristic features, namely, loss and disarray of the smooth muscle cells in the medial layer, loss of elastic fibers, and proteoglycan accumulation in the medial space (reviewed in 2). The compromised integrity of the aortic wall allows progression to dissection. In contrast, the vascular pathology in the occluded arteries of patients with ACTA2 mutations is characterized by enhanced numbers of smooth muscle cells.
Little is known about the underlying biochemical mechanisms by which mutations in SM α-actin trigger pathways that ultimately result in aortic cell loss or in the cell proliferation typical of occlusive diseases in small muscular arteries. Here, we present an in vitro characterization of the defects caused by the R258C mutation in SM α-actin. To our knowledge, we are the first to express the human SM α-actin isoform successfully using the baculovirus/insect cell system, which is a critical aspect of this study because the effect of point mutations can vary depending on the isoform in which they are present. We investigated the effect of the R258C mutation first because of its prevalence in patients (6) , its relatively poor prognosis (median life expectancy of ∼35 y of age), and high penetrance (5) , and because it causes TAAD as well as moyamoya-like disease, an occlusive disease of the cerebral vasculature.
The actin monomer consists of two major domains, with ATP bound in the cleft between them. In the typical view of monomeric globular actin (G-actin), R258 is located in a helix on the backside of subdomain 4 (Fig. 1A) . [Note that the R258 mutation corresponds to amino acid R256 in the actin protein, due to posttranslational processing that removes both the N-terminal Met and Cys residues (7)]. In filamentous actin (F-actin), the outer domain consists of subdomains 1 and 2, as well as the inner domain of subdomains 3 and 4. The two helical strands that compose the filament are stabilized by interactions between protomers both within a strand and between strands. R258C lies at the interface between the two strands ( Fig. 1 B and C) . Upon polymerization, the actin protomer undergoes a conformational change: The two major domains, which are twisted in monomeric G-actin, become flatter with respect to one another in F-actin. Another feature of F-actin is that it can adopt multiple states in which the protomers adopt varied twists and tilts with respect to one another, as well as having different loop conformations (8) (9) (10) (11) .
Significance
Point mutations in vascular smooth muscle α-actin are the most prevalent cause of familial thoracic aortic aneurysms leading to acute dissections, yet the molecular mechanism by which these mutations affect actin function is unknown. An underlying cause of the disease is thought to be contractile dysfunction, which initiates adaptive pathways to repair the defects in the smooth muscle cells. Here, we investigate the effects of the R258C mutation, a prevalent mutation in humans with a poor prognosis. The mutant actin shows multiple defects, including impaired interaction with myosin, formation of less stable filaments, and enhanced levels of monomer. These defects are likely to decrease cellular force production and initiate aberrant mechanosensing pathways that culminate in the disease.
Here, we compare the biochemical properties of expressed WT and R258C SM α-actin, with the goal of understanding how the mutation affects some of the basic functions of actin, because this initial insult ultimately culminates in vascular disease. In smooth muscle cells, force production requires both proper interaction of actin with myosin in the contractile domain and polymerization of actin in the cytoskeletal domain, where it strengthens the membrane for force transmission to the ECM (reviewed in 12). The R258C mutation adversely affects interactions with myosin and weakens filament stability. Our results predict that cells expressing the R258C mutation will have decreased force output and a larger pool of monomeric actin. These dysfunctions could trigger aberrant mechanosensing pathways that culminate in compromised aortic muscle tissue (13) . Increasing the monomer/polymer ratio of actin may also have an impact on cellular phenotype, which could have implications for occlusive vascular disease.
Results
Expression of Human Vascular SM α-Actin. Recombinant human SM α-actin was expressed using the baculovirus/Sf9 insect cell expression system. Several challenges needed to be overcome to achieve this goal: (i) The purified actin could not retain a tag, because both the N and C termini are near the myosin binding site; (ii) contamination by endogenous Sf9 cell actin must be avoided; and (iii) polymerization of actin during expression in the Sf9 cells needed to be prevented because it lowers the protein yield. In addition, expression levels of SM α-actin are considerably lower than what we obtain for β-or γ-cytoplasmic actin. Most of these problems were surmounted by using a method that was designed for expression of toxic actin mutants in Dictyostelium (14) . The C terminus of actin was fused to a 43-aa actin-monomer sequestering protein, thymosin-β4, followed by a HIS tag. Binding of thymosin-β4 to the cleft between subdomains 1 and 3 renders the expressed actin monomeric in the Sf9 cell. The HIS tag allows purification of the expressed actin on a nickel-chelate column. The thymosin-β4-HIS tag is then cleaved from the C terminus of actin by proteolytic digestion with chymotrypsin, whose primary cleavage site is after the last native residue of actin, a Phe. Following ion exchange chromatography to remove the thymosin-β4 and any actin from which the tag was not cleaved, pure actin with no nonnative residues at either the N or C terminus was obtained. This strategy worked equally well for WT and the R258C mutant actin.
SDS gels of the purified WT and R258C actins show the purity of the preparations (Fig. 2A) . The WT actin is shown before and after removal of the thymosin-β4-His tag ( Fig. 2A, lanes 2 and 3) . R258C actin is shown after final purification (Fig. 2A, lane 4) . The two actins were run on a 1D isoelectric focusing gel (Fig. 2B) . As expected, the R258C migrated faster than WT because the mutation replaced a positively charged residue with an uncharged residue. Their relative mobilities were consistent with the calculated isoelectric points of 5.24 for WT and 5.16 for R258C. Average yields of purified actin were ∼0.5 mg of actin for WT and ∼0.4 mg for R258C actin per 10 9 Sf9 cells (200-mL culture). The WT and mutant SM α-actins were compared with regard to their intrinsic ability to polymerize, their interaction with key actin binding proteins (e.g., smooth muscle tropomyosin, profilin, cofilin), and their ability to be moved by smooth muscle myosin under both unloaded and loaded conditions. The mutation significantly affected most of these properties of actin.
R258C Forms a Less Stable Actin Filament. Polymerization of individual SM α-actin filaments was visualized as a function of time using total internal reflection fluorescence (TIRF) microscopy [10 mM imidazole (pH 7.5), 50 mM KCl, 4 mM MgCl 2 , 1 mM EGTA, 2 mM MgATP at 37°C]. The actin filament is polarized such that the two ends differ. The association and dissociation of subunits at the barbed end are intrinsically much faster than at the pointed end. Growth from the barbed end is 10-to 20-fold faster than from the pointed end, and thus we measure total growth from both ends. A series of images at various times illustrate growth of individual filaments ( Fig. 3A and Movie S1). Actin is constant at 10 μM, and DNase is at 10, 5, and 2.5 μM in lanes 3-5 and 6-8. In this gel system, the R258C consistently runs with a slightly faster mobility than WT actin.
R258 E197 K115
The filaments were not visibly different by eye, and filament breaking was rarely observed for either WT or R258C actin. Neither showed delayed polymerization, suggesting that nucleation was normal for both of them. To extract kinetic parameters, the observed increase in filament length was plotted as a function of actin concentration (Fig. 3B ). The slope of each linear plot defines the polymerization rate. The y-intercept is the rate at which actin subunits disassemble from the filament ends. The x-intercept is the critical concentration (i.e., the concentration of monomeric actin in equilibrium with polymer). Average data from five experiments, performed with three independent protein preparations each of WT and R258C actin, are summarized in ), suggesting that the mutant filaments are less stable than WT filaments. The critical concentration for polymerization of R258C actin is approximately fivefold higher than for WT (238 nM vs. 48 nM for WT), which will increase the G-actin concentration in the cell. The defects in polymerization are consistent with the fact that R258 is involved in salt-bridge interactions that stabilize cross-strand interactions in the filament, based on the position of this residue in the pseudoatomic model of the actin filament ( Fig. 1 B and C) .
A human heterozygous for the R258C mutation expresses both WT and mutant actin, and thus we quantified the polymerization of an equimolar ratio of WT and R258C. The rate of elongation of a 50:50 mixture of WT and R258C as a function of actin concentration was intermediate between the values obtained for the two homopolymers, but skewed more toward the rate observed for WT actin (Fig. 4A and Table 2 ). To fit the data, it is assumed that R258C monomers add onto the filament more slowly only when the filament end adopts a "mutant-like" conformation. This simple model is described in more detail in Materials and Methods and Discussion (Fig. 4B) .
Effect of Tropomyosin on Filament Stability. Tropomyosin, an α-helical coiled-coil protein that spans seven actin protomers, is a key component of the smooth muscle thin filament, and it also affects the binding of other actin binding proteins. A cosedimentation assay was used to measure the binding of smooth muscle tropomyosin to WT and mutant filaments. The binding constant (K app ) for tropomyosin to the R258C filaments was similar (3.3 × 10 6 M −1 ) to the K app of the WT filaments (2.3 × 10 6 M −1 ) (Fig. 5 ). When the TIRF polymerization assay was repeated in the presence of smooth muscle tropomyosin, both the assembly and disassembly rates for WT and R258C actin were reduced, but the critical concentration was similar to the critical concentration seen in the absence of tropomyosin (Table 1 ). This result implies that tropomyosin stabilizes the filament by slowing both the addition to and removal of actin monomers from the filament but has no effect on nucleation because tropomyosin does not bind to actin monomers or small nucleating oligomers. Despite the presence of tropomyosin, the R258C filaments remain less stable than WT.
Profilin Binding Is Strengthened by the R258C Mutation. One of the ways in which actin polymerization is regulated is via formins, which enhance filament formation. Formins contain two conserved domains: Formin homology domain 1 (FH1) binds profilin, and formin homology domain 2 (FH2) binds actin (reviewed in 15, 16) . A TIRF polymerization experiment was performed in the presence of the constitutively active FH1-FH2 fragment of mouse diaphanous 1 (mDia1). The presence of formin had no effect on the rate of polymerization of WT, R258C, R258H, or an equimolar mixture of WT and R258C, but it did help nucleate all of them, based on the observed increase in the number of filaments (Fig. 6A ). The mutation thus has little or no effect on the interaction of actin with formin. We compared R258C with R258H in some assays because both mutations lead to the same disease phenotype in humans.
Strikingly, when profilin was added, either alone or in combination with formin, the R258C or R258H actin did not polymerize under our experimental conditions (Fig. 6A ). We thus investigated the effect of profilin alone in more detail. The rate of filament growth was quantified as a function of actin concentration in the presence of 3 μM profilin, using the TIRF polymerization assay (Fig. 6B, dashed lines) . Profilin decreased the polymerization rate for both WT and R258C actin (from 16 to 3.5 subunits per μM (red triangles) as a function of actin concentration. Data were obtained from five experiments using three independent protein preparations each of WT and R258C actin. Values (assembly rate, disassembly rate, and critical concentration) obtained from the fits to a line are provided in Table 1 . Error bars are SE. Data were obtained from five experiments using three independent protein preparations each of WT and R258C actin. Conditions: 10 mM imidazole (pH 7.5), 50 mM KCl, 4 mM MgCl 2 , and 1 mM EGTA (37°C). TM, tropomyosin. *Data were obtained from one experiment. Errors are SE of the fit.
filament ends compared with the free actin monomer. The disassembly rate for both WT and R258C was faster in the presence of profilin compared with its absence (increased from 0.7 to 3 subunits per s −1 for WT and from 2.7 to 8.2 subunits per s −1 for R258C) (Table 3) , which may be due to the unstable configuration of actin at the end of filament when profilin is still bound. Addition of profilin also increases the critical concentration from ∼50 to 330 nM for WT actin because it binds monomeric actin. Unexpectedly, the critical concentration for polymerization of R258C actin increased to a much greater extent in the presence of 3 μM profilin, from ∼240 to 1,680 nM (Table 3 ). This increase may have cellular implications because the level of free actin monomer is tightly controlled in vivo. The data were fitted to a simple model (Materials and Methods) in which both free actin monomer and profilin-actin can take part in the polymerization process. The parameters obtained from the fit show that profilin binds to R258C actin with ∼20-fold higher affinity than to WT (Table 3) .
R258C Filaments Are More Sensitive to the Action of Cofilin. Cofilin is an important regulator of actin dynamics. It has a filament severing activity that increases the number of filament ends, and it depolymerizes filaments from their minus, pointed ends (reviewed in 17). We observed both types of behavior in a TIRF polymerization assay ( Fig. 7 and Movie S2): Filaments were severed internally, and they also shortened from either end, with one end much faster than the other, until the filament disappeared. These two behaviors were not mutually exclusive; namely, a given filament could exhibit one or both behaviors. Both processes depended on cofilin concentration and resulted in the destruction of actin filaments.
We first assessed the effect of cofilin on actin filament shortening. As little as 10 nM cofilin induced shortening of R258C filaments (Fig. 7A) . At 100 nM cofilin, the process was so fast that no R258C filaments were observed by the time the slide was mounted on the microscope. In contrast, WT filaments only started to slowly shorten at 100 nM cofilin.
WT filaments were also more resistant than R258C filaments to severing by cofilin (Fig. 7B) . WT filaments showed virtually no severing at 100 nM cofilin, whereas with 75 nM cofilin, severing events were frequently observed with R258C filaments.
Binding of cofilin is competitive with tropomyosin (reviewed in 17). Tropomyosin reduced the rate of shortening and strongly suppressed the severing effects of cofilin with WT actin filaments (Fig. 7) . Even at 1.2 μM cofilin, there was minimal shortening and almost no severing. In contrast, the R258C filaments were much more vulnerable to attack by cofilin despite the presence of tropomyosin. Smooth muscle tropomyosin binds at least as tightly to R258C filaments as to WT filaments (Fig. 5) , so low binding affinity does not explain the result.
DNase and Gelsolin Binding Are Unaffected. To assess if the R258C mutation affects its binding to DNase and gelsolin segment-1 qualitatively, actin was incubated with varying molar ratios of actin to binding protein, and actin complexes were separated from monomers on native gels. Fig. 2C shows the results with DNase, but essentially identical gels were obtained with gelsolin segment-1. In both cases, there was no obvious difference in the amount of complex formed with WT and the R258C actin.
R258C Actin Filaments Are Propelled at Slower Speeds than WT. An unloaded in vitro motility assay was used to measure the speed at which smooth muscle myosin moves WT vs. R258C actin. We first performed the typical motility assay using filaments that were stabilized and visualized using rhodamine-phalloidin. Mutant and WT filaments were moved at the same speed (Fig. 8A) . In the presence of smooth muscle tropomyosin, WT actin moved ∼40% faster than bare actin. In contrast, the speed at which myosin moved the R258C filaments was not enhanced by tropomyosin. This increase in speed resulted in WT filaments moving ∼1.7-fold faster than R258C filaments in the presence of tropomyosin.
The in vitro motility was repeated in the absence of phalloidin to test if this compound, which stabilizes the filament, moderates the defects caused by the mutation. To visualize the filaments, WT actin was directly labeled with rhodamine and incorporated into the filament as 25% of the total actin. The speed of filament movement slowed as the percentage of R258C actin in the filament Conditions: 10 mM imidazole (pH 7.5), 50 mM KCl, 4 mM MgCl 2 , and 1 mM EGTA (37°C). *Details of the model are described in Discussion.
increased from 50-75% (Fig. 8B) . The slowing of speed by the mutant actin was accentuated in the presence of tropomyosin.
In some patients, Arg-258 is mutated to His instead of Cys. We expressed and purified R258H to test if this mutation had similar effects to R258C. In filaments containing 75% mutant actin, speeds were comparable whether the Arg residue was mutated to Cys or His (minus tropomyosin: 0.47 ± 0.13 for R258C vs. 0.50 ± 0.10 for R258H; plus tropomyosin: 0.31 ± 0.08 for R258C vs. 0.32 ± 0.09 for R258H).
To determine if the slowing of speed with the mutant actin filament was due to a change in the rate of release of ADP from myosin, a stopped-flow experiment was performed. Acto-smooth heavy meromyosin (HMM)-ADP was mixed with 2 mM MgATP. Under these conditions, the rate of acto-HMM dissociation is rate-limited by ADP dissociation. The rate of ADP release from the mutant and WT filament was the same (134 ± 1 s −1 for WT actin and 127 ± 1 s −1 for R258C actin).
Actomyosin Force Generation Is Severely Impaired When Tropomyosin
Is Bound to the R258C Filament. To test if the R258C mutation affects force generation by myosin, we carried out a one-bead laser trap experiment to investigate the force/velocity relationship of a small ensemble of smooth muscle heavy meromyosin with WT and R258C actin filaments (Fig. 9A) . When studying actin mutants, an advantage of the one-bead setup is that the actin filaments do not require phalloidin for stabilization because they are attached to the coverslip. In the more traditional three-bead assay, the actin is suspended between two beads and stabilized with rhodamine-phalloidin. We first compared the force/velocity relationship obtained with bare WT and R258C actin filaments. A force-feedback system is used to clamp the force at five levels between 1 and 5 pN. The velocity at any force level was obtained by fitting the raw data to a line (Fig. 9B) . The force/velocity relationship was then fitted to the Hill equation. As expected, velocity slowed as force increased (Fig. 9C) . There was virtually no difference between the curves obtained with bare WT vs. bare R258C filaments. In the presence of smooth muscle tropomyosin, the WT filament showed the same force/velocity relationship as in its absence. In contrast, velocity was greatly reduced at all force levels for R258C actin-tropomyosin filaments.
Discussion
Multiple facets of SM α-actin function are quite severely affected by the R258C mutation. Defects induced by the R258C mutation include (i) slower and less productive interactions with smooth muscle myosin, particularly in the presence of tropomyosin, that lead to reduced force output; (ii) formation of a less stable filament with greater susceptibility to cleavage by cofilin even in the presence of tropomyosin, which enhances actin filament dynamics; and (iii) higher affinity binding to profilin, which increases the monomeric pool of actin. How these in vitro defects affect smooth muscle cell function must be viewed in light of the many roles that SM α-actin plays in vascular smooth muscle cells. These roles include production of contractile force, maintenance of the integrity of the submembrane cytoskeleton, cellular mechanosensing, and regulation of cell differentiation and proliferation. Genetic mutations that predispose patients to TAAD include mutations in the contractile proteins and their regulators, ECM structural components of the aortic wall, and proteins involved in mechanosensing. It has been proposed that smooth muscle cell contractile dysfunction is one of the primary insults that activates the stress and strain pathways that initiate maladaptive remodeling of the smooth muscle cell, ultimately culminating in an aortic aneurysm (reviewed in 2, 13).
Actin is found in two distinct domains in smooth muscle cells. The "contractile" domain of smooth muscle cells consists of interdigitating myosin and stable actin filaments that cyclically interact to generate tension, controlled by phosphorylation of the regulatory light chain of smooth muscle myosin. These filaments are anchored . The Hill coefficient is 1.9 for WT, and the Hill coefficient is 2.3 for R258C. Data obtained from three independent pelleting assays are shown.
into dense bodies, a structure characteristic of smooth muscle cells. A second "cytoplasmic" domain located in the subcortical region has a more dynamic pool of actin that is not associated with myosin. At the membranous dense plaques, this pool of actin attaches to the cytoplasmic tails of transmembrane integrins via focal adhesion proteins, which transduce mechanical force across the plasma membrane by linking the ECM with the cytoskeleton.
A unique feature of tension development in smooth muscle cells is that the independently regulated contractile domain and cytoskeletal domains need to collaborate to produce force. This view is supported by numerous studies showing that in response to stimulation, the amount of F-actin in the cell increases, and if this new actin polymerization is blocked, tension is not developed (reviewed in 12, [18] [19] [20] . The mechanism by which actin polymerization facilitates force production may include an enhancement of the linkage of the actin filaments to integrins, which would strengthen force transduction between the contractile domain and the ECM. Approximately 10% of the actin undergoes polymerization, so that a resting cell has ∼70-80% F-actin, which increases to ∼80-90% after stimulation. Whether both smooth and cytoskeletal actin isoforms undergo polymerization upon stimulation remains unresolved (21, 22) . Moreover, when the cell contains a mutant SM α-actin, such as R258C, which appears to be more dynamic than WT α-actin, it may more readily become part of both the contractile and cytoskeletal pools of actin. Our results suggest that the R258C mutation has the potential to disrupt the function of actin in both domains.
R258C Mutation Decreases Contractile Function by Perturbing Interactions
with Both Myosin and Tropomyosin. Under unloaded conditions, the presence of R258C in the actin filament slowed the speed of myosin-powered movement in an in vitro motility assay in a dosedependent fashion. Phalloidin stabilization of the filament suppresses this defect. Two general mechanisms can lead to slower movement. One is a change in myosin kinetics, and the other is via a change in the properties of the actin filament per se. The kinetic step in myosin that controls actin motility speed is ADP release. Because we observed no change in the rate of ADP release, we favor a mechanism whereby the structure of the mutant filament does not allow the full displacement per working stroke of myosin to be realized, resulting in less displacement per MgATP hydrolyzed, and thus a slower speed.
Tropomyosin occupies a more inhibitory position on R258C actin filaments. In the absence of myosin and troponin, the latter of which is not present in smooth muscle cells, all tropomyosins occupy either the blocked or closed state on actin (23) . In the blocked state, tropomyosin sterically prevents myosin from binding to actin. In the closed state, myosin can bind weakly, and additional binding of myosin cooperatively shifts tropomyosin to the open state, which fully exposes the myosin binding site. In the presence of tropomyosin, the difference in speed between WT and mutant filaments was accentuated. More strikingly, once load was applied, myosin was essentially unable to interact with R258C actin-tropomyosin filaments. In the loaded assay, only a small number of myosin heads interact with the actin-tropomyosin filament at any time, and this number appears to be insufficient to displace tropomyosin from an inhibitory position.
That defects in force output from the contractile domain can lead to TAAD is further supported by the fact that loss-of-function mutations in both the myosin heavy chain (MYH11) and myosin light chain kinase (MLCK), which phosphorylates the regulatory light chain of myosin and is required for actomyosin interactions, also cause autosomal dominant inheritance of TAAD (24, 25) . Genes encoding proteins involved in either smooth muscle cell contraction or the TGF-β signaling pathway are the predominant causes of familial TAAD.
R258C Destabilizes the Filament. Although R258C was not specifically looked at, immunofluorescence of cultured smooth muscle cells from individuals with ACTA2 mutations showed substantially fewer actin filaments than controls, suggesting that these mutations may interfere with actin assembly (3). Our in vitro results support this idea. R258C actin has a higher critical concentration for assembly, caused by a slower rate of assembly and a faster rate of disassembly. Based on the location of R258 in the model of the actin filament structure (Fig. 1) , a polymerization defect was predictable. Recent advances in electron cryomicroscopy have led to the highest resolution structures (3.7-4.7 Å) of the actin filament to date (9, 11) . In these structures, R258 (R256 in protein) forms a salt bridge with E197 (E195 in protein) in the same protomer, which, in turn, forms a salt bridge with K115 (K113 in protein) on the cross-strand actin ( Fig. 1 B and C) . This stabilizing salt bridge triad will be disrupted upon mutation of R258 to either Cys or His, which changes both side-chain size and charge. Mutation of R258 to either Cys or His causes similar patient phenotypes. Filament destabilization as a result of an R256H mutation (equivalent to residue Arg-258 in ACTA2) was first observed in the backbone of Saccharomyces cerevisiae actin by Malloy et al. (26) . Ionic crossstrand stabilization that involves this residue thus appears to be a property common to SM α-actin and budding yeast actin. Copolymerization of equal amounts of WT and mutant actin tempers the polymerization defect. The observation that polymerization as a function of actin concentration was skewed toward the WT values could be explained by a simple model if we make the following two assumptions (Fig. 4 and Materials and Methods). First, only when an R258C monomer adds onto a filament that adopts a mutant-like conformation (e.g., a filament with a mutant protomer at the barbed end) will it assemble at a slow rate similar to the rate observed for the R258C homopolymer. In all other scenarios, the monomer adds onto the filament with a faster rate that approximates the WT assembly rate. Second, the disassembly rate depends solely on the actin type (i.e., WT dissociates with the WT disassembly rate, R258C dissociates from filaments with the R258C disassembly rate). As shown in Table 2 , the calculated results from this model agree with the experimentally observed values. ; n = 170) decreased to 0.43 ± 0.09 μm·s −1 (n = 80) with 50% R258C and to 0.31 ± 0.081 μm·s −1 (n = 142) with 75% R258C.The difference between all pairs was statistically significant (Student's t test, P < 0.01). Data from five independent actin preparations were pooled. Filament speed was tracked manually. Temperature, 30°C. and plasma membrane invagination during endocytosis and phagocytosis. Assembly is regulated by proteins, including formin and Arp2/3, that control nucleation and polymerization (reviewed in 15), and it is balanced by disassembly of older filaments by proteins in the ADF/cofilin family, which preferentially bind ADPactin monomers (reviewed in 17). Cofilin accelerates remodeling of the actin network by severing actin filaments, and thus increasing the concentration of ends available for elongation and subunit exchange. Cofilin also depolymerizes filaments from the pointed ends, thereby increasing filament dynamics (27) . Cofilin is, however, also present in striated muscle cells that are considered to have considerably more stable actin filaments. In striated muscle cells, cofilin is thought to be involved in precise length control of the thin filament (28, 29) . In vascular smooth muscle cells, increased cofilin activation upon dephosphorylation with slingshot phosphatase 1 has been implicated in vascular smooth muscle cell migration and neointima formation following vascular injury (30) . Here, we show that R258C actin filaments are considerably more susceptible to cleavage by cofilin and show increased levels of shortening, compared with WT filaments. In essence, the increased sensitivity of R258C to cofilin should have the same effect as having more activated, unphosphorylated cofilin. Our results suggest that mutation of R258 is likely to result in enhanced actin dynamics and cell migration.
Laser trap
Although the molecular mechanism of severing is not known, it is affected by the structure and mechanical properties of the actin filament (31), which differ when R258 is mutated. Moreover, although binding of smooth muscle tropomyosin protects the WT filament from cofilin cleavage (32), the same is not true for the R258C filaments. This observation supports the idea that the position of tropomyosin on WT vs. R258C filaments differs, consistent with the inhibitory effect of tropomyosin on force and motion generation by myosin when it interacts with the mutant actin.
R258C Increases the Monomeric Pool of Actin by Binding Profilin
Tightly. Profilin, one of the most abundant actin binding proteins inside the cell, binds to monomeric actin with high affinity and is the predominant substrate for actin assembly in vivo. Formins accelerate polymerization by increasing the local concentration of actin-profilin at the barbed end (reviewed in 15, 16) . Here, we show that the affinity of R258C actin for profilin is ∼20-fold higher than to WT. This tight binding decreases formin-mediated actin polymerization. The net result is that in cells containing R258C actin, we predict that the pool of monomeric actin is considerably larger than in WT cells. Another prediction is that more WT monomers will be incorporated into the actin filaments than the mutant in cells expressing both, potentially attenuating the detrimental effect of the mutant actin. The tighter binding to profilin is unexpected because the profilin binding site to actin is far from the location of the R258C mutation. This tight binding indicates the R258C mutation changes not only the actin filament structure but also the conformation of monomeric actin.
A previous study investigated the effect of mutating this same Arg residue to His in the backbone of budding yeast actin, which is only 86% identical to SM α-actin (26) . The major defect those investigators observed in vitro was that yeast formin (Bni1) did not enhance polymerization but, instead, strongly capped the filament end. This result was consistent with their cellular results in which budding yeast cells expressing the mutant actin were delayed in their ability to rebuild their actin cytoskeleton following a challenge by the actin-depolymerizing drug latrunculin A. Although we also observed intrinsic polymerization defects with this mutation, and altered interaction of R258C with profilin and cofilin, our results did not show a defect in the mutant actin's interaction with formin for either R258H or R258C. We conclude that the effect of vascular disease-causing mutations is best studied in the SM α-actin backbone rather than a heterologous system.
A potential downstream effect of increasing the amount of monomeric actin in the cell is altering smooth muscle cell phenotype. The subcellular localization of the actin binding transcriptional cofactor myocardin-related transcription factor (MRTF-A) depends on the relative amount of monomeric vs. F-actin. When G-actin concentration in the cytoplasm increases, it binds to MRTF-A and retains it in the cytoplasm. Conversely, upon Rho-A-dependent actin polymerization, MRTF-A accumulates in the nucleus. Once in the nucleus, it interacts with serum response factor, which binds to conserved CC[A/T] 6 GG cis-elements within the smooth muscle cell-specific promoters to activate transcription of smooth muscle-specific genes (reviewed in 33, 34). Thus, a potential outcome is that cells containing R258C actin may lead to the smooth muscle cell developing a less contractile and more proliferative phenotype, because the increased monomeric pool may sequester MRTF-A in the cytoplasm.
Allosteric Effects of the R258C Mutation. A number of the observed defects in R258C were unexpected based solely on its location in actin. These defects include altered binding of smooth muscle tropomyosin and tighter binding of the mutant actin to profilin. The mutant residue is not directly part of the myosin, tropomyosin, or profilin binding site. These latter unexpected changes suggest new pathways of allosteric communication within the actin monomer that have been disturbed by the mutation. An allosteric connection between the profilin binding site and R258 is consistent with results from a hydrogen/deuterium exchange and MS study showing that Arg-258 and residues at the profilin binding site were on a connected block of residues that display similar hydrogen/deuterium exchange kinetics (35) . Reciprocally, a protein binding at the profilin site at the barbed end can propagate a conformation change that locally alters the conformation of residue 258 at an interstrand filament stabilization site, which may provide insight into how profilin at low concentrations can facilitate actin polymerization.
A prevailing argument for the extreme conservation of sequence in actin is that virtually every residue has been placed under selective pressure because of the internal networks within the actin filament that are needed to maintain such allosteric linkages (reviewed in 36). Our results provide additional evidence to support this point of view.
Perspective. Fig. 10 shows a schematic of potential differences between a WT smooth muscle cell and a cell expressing both WT and R258C actin. The overall goal of characterizing the functional effect of actin point mutations at the molecular level is to determine if the The left-hand portion of the schematic cell illustrates that myosin interacts productively with WT actintropomyosin to produce force and motion. Most actin is filamentous, with only a small pool of monomeric actin. The filaments that are decorated with tropomyosin are resistant to severing and shortening by cofilin. In contrast, cells expressing both WT and R258C actin would be expected to show slower filament sliding and have a lower force output. Moreover, it is expected that the pool of monomeric actin will increase relative to WT cells, because R258 has a higher critical concentration, a higher affinity for profilin, and is more susceptible to severing and shortening by cofilin.
observed defects can be correlated with vascular disease outcomes and with patient survival rates. This study is the first step toward that goal. For example, both R258C and R39H lead to TAAD and moyamoya-like cerebrovascular disease, whereas other mutations lead only to TAAD (e.g., W88R, G160D) and still others lead to TAAD and coronary artery disease (e.g., R149C, R118Q). "Loss-offunction" mutations that lead to smooth muscle cell weakness, a failure of tension sensing, and degeneration are thought to lead to thoracic aneurysms and aortic dissections. With R258C, we have evidence for loss of contractile function. In contrast, "gainof-function" mutations that lead to cell proliferation and increased motility, or hyperplastic arterial smooth muscle cell growth, might lead to occlusive vascular diseases. With R258C, pathways that lead to cell proliferation could be mediated via the observed altered interactions of R258C filaments with cofilin and profilin, leading to increased pools of monomeric actin, and by the intrinsic lability of the mutant filament. The R258C mutation affects essentially all aspects of actin function that we measured in vitro. Cellular studies with fibroblasts and smooth muscle cells derived from patients with the R258C mutation, or mouse models, will establish how these defects are manifested in a cellular context.
Materials and Methods
Details of cloning, expression, and purification of proteins used in this study; the tropomyosin binding assay; actin labeling and filament formation for motility; the in vitro motility assay; measurement of ADP dissociation rates; and force data acquisition and analysis are provided in SI Materials and Methods.
Actin Cloning, Expression, and Purification. A chimeric construct composed of human SM α-actin (ACTA2 gene; accession number NP_001604) and human thymosin-β4 (accession number AAI41977.1) was cloned into pAcUW2B for expression in the baculovirus/insect cell system. The initial Cys residue of actin was not included in the construct because it is not present in the mature, processed protein. The thymosin-β4 gene was separated from the actin gene by a 14-aa linker (ASSGGSGSGGSGGA) to allow the thymosin-β4 enough flexibility to occupy the barbed end binding site on the actin monomer, thus preventing the actin from polymerizing with itself or native Sf9 cell actin. A HIS 6 tag was added at the C terminus for purification on a nickel affinity column. The final native residue of actin is Phe, which provides a site for chymotrypsin cleavage to remove the linker, thymosin-β4, and the HIS 6 tag completely. The native codons for both actin and thymosin-β4 were replaced with Drosophila preferred codons. For expression of human SM α-actin, infected Sf9 cells (4 × 10
9
) were harvested 3 d after infection and lysed in 160 mL of 1 M Tris·HCl (pH 7.5 at 4°C), 0.6 M NaCl, 0.5 mM MgCl 2 , 0.5 mM Na 2 ATP, 1 mM DTT, 4% (vol/vol) Triton X-100, 1 mg/mL Tween-20, and protease inhibitors [0.5 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride, 5 μg/mL leupeptin, 0.5 mM tosyllysine chloromethyl ketone hydrochloride]. The cells were stirred for 2 h and then clarified. The soluble fraction was dialyzed overnight against 10 mM Hepes (pH 7.5), 0.25 mM CaCl 2 , 0.3 M NaCl, 7 mM β-mercaptoethanol, 0.25 mM Na 2 ATP, and 1 μg/mL leupeptin. Following dialysis, the supernatant was applied to 5-10 mL of a nickel affinity column (HIS-Select; Sigma-Aldrich). Nonspecifically bound contaminating proteins were washed off with dialysis buffer containing 10 mM imidazole (pH 7.5). Actin was eluted with 100 mM imidazole, 10 mM Hepes (pH 7.5), 0.25 mM CaCl 2, 0.3 M NaCl, 7 mM β-mercaptoethanol, 0.25 mM Na 2 ATP, and 1 μg/mL leupeptin. The peak fractions were pooled and dialyzed overnight against G-buffer [5 mM Tris (pH 8.26 at 4°C), 0.2 mM CaCl 2 , 0.1 mM NaN 3 , 0.5 mM DTT, 0.2 mM Na 2 ATP, 1 μg/mL leupeptin]. The protein was clarified by centrifugation, and the thymosin-HIS tag was cleaved from the actin with chymotrypsin (chymotrypsin/actin in a 1:80 weight ratio). The actin was separated from the thymosin-His tag using a Mono Q 5/50 GL column (GE Healthcare) with a gradient of 0-0.3 M NaCl in 5 mM Tris (pH 8.26 at 4°C), 0.2 mM CaCl 2 , 0.1 mM NaN 3 , 0.5 mM DTT, 0.2 mM Na 2 ATP, and 1 μg/mL leupeptin, followed by a step to 0.5 M NaCl. Peak fractions were pooled, concentrated, and dialyzed against 5 mM Tris (pH 8.26 at 4°C), 0.2 mM CaCl 2 , 0.1 mM NaN 3 , 0.5 mM DTT, 0.2 mM Na 2 ATP (pH 7), and 1 μg/mL leupeptin.
Actin Polymerization Visualized by TIRF Microscopy. The 2× polymerization buffer consists of 20 mM imidazole (pH 7.5), 100 mM KCl, 8 mM MgCl 2 , 2 mM EGTA, 0.5% methylcellulose, 4 mM MgATP, 0.26 mg/mL glucose oxidase, 0.10 mg/mL catalase, 6 mg/mL glucose, and 20 mM DTT. The rinse buffer is composed of equal volumes of G-buffer [5 mM Tris (pH 8.26 at 4°C), 0.2 mM CaCl 2 , 0.2mM Na 2 ATP, 0.5 mM DTT] and 2× polymerization buffer.
Lifeact-GFP was used to visualize the actin filaments. Lifeact binds weakly to F-actin (K d of ∼2 μM), and as much as 55 μM Lifeact was shown not to affect the rates of polymerization and depolymerization (37) . This probe allows us to use unlabeled WT and mutant actin. Previous methods for visualizing actin polymerization have relied on actin that has been modified either at Cys374 or at Lys residues (38, 39) . In our study, direct modification of actin is complicated both by the low yields of expressed actin and by our observation that R258C actin does not label in a manner identical to the WT actin. Actin in G-buffer was spun for 30 min at 392,148 × g. The supernatant concentration was determined by a Bio-Rad Protein Assay. The typical actin concentration is 1-2 mg/mL. To prepare the flow cell, 20 μL of 5 μg/mL N-ethyl maleimide-myosin was flowed in and incubated for 2 min. The flow cell was rinsed with 20 μL of 5 mg/mL casein, and then with 20 μL of rinse buffer. Twenty microliters of G-actin (1-5 μM, also containing 1.64 μM Lifeact) in G-buffer was mixed with 20 μL of 2× polymerization buffer to start the polymerization. The mixture was then flowed into the flow cell (two times, 20 μL each time). Excess solution was removed, and the flow cell was sealed with nail polish. The flow cell was immediately put on a Nikon ECLIPSE Ti microscope equipped with throughobjective type TIRF and a temperature control unit (37°C). The samples were excited with the TIRF field of a 488-nm laser line. The fluorescence image was observed with a 100× objective and recorded on an Andor EMCCD camera (Andor Technology USA) at a rate of one frame per second for 1-3 min with automatic focus correction. The final resolution is 0.1066 μm per pixel.
For experiments with profilin, 1 μL of 120 μM profilin (3 μM final) was added to the final 40-μL mixture. For experiments with tropomyosin, various amounts of tropomyosin were added to the mixture so that the final tropomyosin concentration was one-fourth the concentration of the actin monomer. For experiments with cofilin, actin was first polymerized at 37°C for a few minutes in the flow cell while being monitored on the microscope. Once the filaments reached the desired length and density, 20 μL of G-buffer containing various amounts of cofilin and 1.64 μM Lifeact was mixed with 20 μL of 2× polymerization buffer and then flowed into the flow cell. The flow cell was then sealed with nail polish before observation on the microscope.
Fluorescence Data Processing. Movies following actin polymerization or depolymerization as a function of time were imported into ImageJ (National Institutes of Health). The growth or shrinkage was followed manually. The polymerization rate was obtained by dividing the total growth by time. Rate was converted from micrometers per second to subunits per second by multiplying by the converting factor of 370 actin subunits per micrometer. For each condition, 15-50 growing filaments were measured.
Rates of polymerization were plotted against the actin monomer concentration. The data were linearly fit to Rate = a[actin] + d, in which a is the second-order assembly rate of polymerization, d is the first-order rate of disassembly, and the critical concentration is −d/a.
To determine the frequency of severing for experiments with cofilin, the total number of severing events (actin filaments that clearly broke into two pieces) was counted for each 1 min of video and then divided by the total actin filament length in the field of view at the starting frame of this 1-min video. Shortening of actin by cofilin was traced manually and then divided by time.
Modeling of Polymerization Data in the Presence of Profilin. The following assumptions were made to model the polymerization of G-actin in the presence of profilin. Monomeric G-actin and profilin form a profilin-G-actin complex with affinity K d . Both G-actin and profilin-G-actin can participate in the polymerization process, with rates of r a and r ap , respectively. Protomers dissociate from F-actin with rate r d . The overall scheme is described in the following equations: Modeling of Polymerization of Mixtures of WT and R258C. In this scheme, as illustrated in Fig. 4B , the rate of association of G-actin to the end of an F-actin filament, and the dissociation of G-actin from F-actin, depends on the composition of the barbed end of the F-actin polymer. For polymerization, if the last actin in F-actin is WT, then both the WT and R258C G-actin monomers add to the F-actin with a rate of r w (WT association rate). If the end unit of F-actin is R258C, then a WT G-actin will add onto it with a rate of r w , but an R258C
